Cancer Cells Differentially Activate and Thrive on De Novo Lipid Synthesis Pathways in a Low-Lipid Environment

por Daniëls, Veerle W., Smans, Karine, Royaux, Ines, Chypre, Melanie, Swinnen, Johannes V., Zaidi, Nousheen
Publicado 2014

Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer

por Zoeller, Jason J., Vagodny, Aleksandr, Daniels, Veerle W., Taneja, Krishan, Tan, Benjamin Y., DeRose, Yoko S., Fujita, Maihi, Welm, Alana L., Letai, Anthony, Leverson, Joel D., Blot, Vincent, Bronson, Roderick T., Dillon, Deborah A., Brugge, Joan S.
Publicado 2020

Identification of drugs that restore primary cilium expression in cancer cells

por Khan, Niamat Ali, Willemarck, Nicolas, Talebi, Ali, Marchand, Arnaud, Binda, Maria Mercedes, Dehairs, Jonas, Rueda-Rincon, Natalia, Daniels, Veerle W., Bagadi, Muralidhararao, Raj, Deepak Balaji Thimiri Govinda, Vanderhoydonc, Frank, Munck, Sebastian, Chaltin, Patrick, Swinnen, Johannes V.
Publicado 2016

Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma

por Mai, Wilson X., Gosa, Laura, Daniels, Veerle W., Ta, Lisa, Tsang, Jonathan E., Higgins, Brian, Gilmore, W. Blake, Bayley, Nicholas A., Harati, Mitra Dehghan, Lee, Jason T., Yong, William H., Kornblum, Harley I., Bensinger, Steven J., Mischel, Paul S., Rao, P. Nagesh, Clark, Peter M., Cloughesy, Timothy F., Letai, Anthony, Nathanson, David A.
Publicado 2017

Lipid availability determines skeletal progenitor cell fate via SOX9

por van Gastel, Nick, Stegen, Steve, Eelen, Guy, Schoors, Sandra, Carlier, Aurélie, Daniëls, Veerle W., Baryawno, Ninib, Przybylski, Dariusz, Depypere, Maarten, Stiers, Pieter-Jan, Lambrechts, Dennis, Van Looveren, Riet, Torrekens, Sophie, Sharda, Azeem, Agostinis, Patrizia, Lambrechts, Diether, Maes, Frederik, Swinnen, Johan V., Geris, Liesbet, Van Oosterwyck, Hans, Thienpont, Bernard, Carmeliet, Peter, Scadden, David T., Carmeliet, Geert
Publicado 2020